trending Market Intelligence /marketintelligence/en/news-insights/trending/8Jz1TFMcQc0hsuXONdBrQQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aclaris Therapeutics adds director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aclaris Therapeutics adds director

Aclaris Therapeutics Inc. added Andrew Schiff to its board.

Schiff is a managing partner at Aisling Capital LLC.